KeyBanc lowered the firm’s price target on Eastman Chemical (EMN) to $79 from $93 and keeps an Overweight rating on the shares. The firm says that as disappointing as Eastman’s Q2 was, it wouldn’t have expected a 19% stock decline. While KeyBanc is revising 2025 EPS 18% lower, the firm judges about half of this revision is temporary in nature.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN: